SB성보 Stock: price and insider trades · South Korea

This page follows insider dealings at SB성보 as filed with DART (FSS), a company from the Health Care sector. Between 18 October 2025 and 18 October 2026, 2 insiders published 6 filings.

All open-market trades in the period are sales: 1 sale, by 1 insider, with no purchase on record. The totals do not cover 1 filing with an undisclosed amount.

The median gap between a trade and its publication by DART (FSS) is 6 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

Across the 2,648 companies tracked on its exchange, the median is 7 filings; at 6 filings, this issuer sits below that mark. Our records for SB성보 go back to 2021, with 7 purchases and 1 sale on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.